Robert P. Giugliano on Muck Rack

Robert P. Giugliano

As seen in: Color Research & Application, JAMA (The Journal of the American Medical Association), JAMA Cardiology, Medscape, The New England Journal of Medicine, The European Heart Journal, The Lancet, MedPage Today, AHA/ASA Journals, Healio and
Physician, Cardiovascular Medicine Brigham and Women's Hospital, Professor Harvard Medical School
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robert P.

Contact Robert P., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Obesity-Associated Cardiovascular Risk and Benefit From PCSK9 Inhibition: A Prespecified Analysis From FOURIER

|
By Robert P. Giugliano, Anthony C Keech, J. Antonio G. López
| JACC (Journal of the American College of Cardiology)
The prevalence of worldwide adult obesity has more than doubled since 1990, contributing to the rapid rise in obesity-related health risks.1 In particular, obesity is a significant contributor to the development of atherosclerotic cardiovascular disease (ASCVD), which accounts for the majority of deaths for those with elevated body mass index (BMI).2 Obesity is believed to contribute to atherogenesis and atherothrombosis through a variety of direct and indirect pathways including its...
Open in Who Shared Issue with article?

Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy

|
By André Nicolau, Robert P. Giugliano, André Zimerman, Jonathan Afilalo
| JACC (Journal of the American College of Cardiology)
Get full access to this article View all available purchase options and get full access to this article. Supplementary Material Supplemental Tables 1 and 2 and Supplemental Figures 1-4 (mmc1.docx) Supplemental Material (mmc2.docx) References 1. Pisters R., Lane D.A., Nieuwlaat R. A novel user-friendly score (HAS BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation. CHEST J. 2010;138:1093-1100. https://doi.org/10.1378/chest.10-0134. 2.
Open in Who Shared Issue with article?

Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71

|
By Siddharth Patel, Robert P. Giugliano, David A. Morrow, Sanobar Parkar
| JACC (Journal of the American College of Cardiology)
References 1. "Epidemiology and modifiable risk factors for atrial fibrillation". Nat Rev Cardiol . 2023;20:404-417. 2. "2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". J Am Coll Cardiol . 2024;83:1: 109-279. 3.
Open in Who Shared Issue with article?
See all 49 licensed articles (51 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified